Joan W Miller Selected Research

Choroidal Neovascularization

11/2019	RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization.
1/2017	Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.
7/2012	The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.
11/2011	Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration.
7/2011	Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization.
6/2011	In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography.
5/2011	Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography.
11/2008	Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.
6/2008	Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.
1/2008	Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan W Miller Research Topics

Disease

47	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 03/2002
30	Choroidal Neovascularization 11/2019 - 03/2002
18	Inflammation (Inflammations) 01/2023 - 03/2002
18	Retinal Detachment (Retinal Detachments) 01/2023 - 03/2003
10	Glaucoma 03/2024 - 09/2002
9	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2022 - 02/2007
9	Neoplasms (Cancer) 01/2017 - 07/2007
7	Retinoblastoma (Glioblastoma, Retinal) 12/2014 - 01/2005
5	Necrosis 12/2022 - 07/2004
5	Eye Diseases (Eye Disease) 03/2016 - 02/2005
5	Uveitis 06/2012 - 07/2007
4	Strabismus (Squint) 02/2024 - 01/2022
4	Atrophy 10/2021 - 05/2012
4	Geographic Atrophy 06/2021 - 09/2010
4	Pathologic Neovascularization 11/2019 - 08/2003
3	Myopia 01/2023 - 04/2003
3	Retinal Vein Occlusion 04/2022 - 02/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2004
3	Cataract (Cataracts) 01/2019 - 01/2010
3	Uveal melanoma 01/2017 - 04/2014
3	Infections 04/2013 - 09/2005
3	Ganglion Cysts (Ganglion) 08/2006 - 02/2005
2	Blindness (Hysterical Blindness) 01/2022 - 01/2014
2	Vision Disorders (Hemeralopia) 03/2021 - 07/2015
2	Retinal Diseases 01/2021 - 06/2007
2	Corneal Neovascularization 11/2019 - 07/2012
2	Wounds and Injuries (Trauma) 01/2019 - 09/2014
2	Hemorrhage 01/2019 - 03/2002
2	Neuroinflammatory Diseases 01/2019 - 01/2018
2	Retinal Neovascularization 01/2014 - 08/2003
2	Endophthalmitis (Ophthalmia) 04/2013 - 09/2005
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2012 - 06/2011
2	Multiple Sclerosis 10/2011 - 02/2007
2	Back Pain (Backache) 02/2004 - 10/2002
1	Low Vision (Subnormal Vision) 03/2024
1	Herpetic Keratitis 11/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Macular Edema 09/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2021

Drug/Important Bio-Agent (IBA)

21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 03/2002
20	Retinaldehyde (Retinal)IBA 01/2023 - 08/2003
14	Verteporfin (Visudyne)FDA Link 01/2017 - 07/2002
11	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2010 - 07/2002
7	Phosphotransferases (Kinase)IBA 11/2019 - 08/2010
6	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 04/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 08/2006
5	LipidsIBA 01/2024 - 12/2016
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 07/2008
5	Hyaluronic Acid (Hyaluronan)IBA 05/2014 - 03/2003
5	AICA ribonucleotide (ZMP)IBA 04/2014 - 08/2010
5	Complement Factor H (Factor H)IBA 10/2011 - 01/2007
5	CaspasesIBA 06/2011 - 03/2003
4	Complement System Proteins (Complement)IBA 04/2022 - 12/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2006
4	EndotoxinsIBA 08/2011 - 07/2007
3	Protein Kinases (Protein Kinase)IBA 01/2023 - 12/2010
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2008
3	InflammasomesIBA 01/2019 - 12/2016
3	CytokinesIBA 11/2015 - 11/2005
3	Adenosine Monophosphate (AMP)IBA 04/2014 - 08/2010
3	Ranibizumab (Lucentis)FDA Link 07/2013 - 04/2005
3	Receptor-Interacting Protein Serine-Threonine KinasesIBA 09/2012 - 12/2010
3	Cell Adhesion MoleculesIBA 08/2008 - 06/2003
3	Immunoglobulin FragmentsIBA 06/2005 - 03/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2021 - 01/2007
2	Indicators and Reagents (Reagents)IBA 11/2018 - 07/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 11/2010
2	Protons (Proton)IBA 09/2014 - 11/2006
2	Photosensitizing Agents (Photosensitizers)IBA 07/2014 - 01/2004
2	CyclinsIBA 04/2014 - 01/2013
2	Bevacizumab (Avastin)FDA Link 07/2013 - 11/2011
2	Peptide Hydrolases (Proteases)FDA Link 10/2011 - 07/2008
2	Serine (L-Serine)FDA Link 10/2011 - 07/2008
2	Cytochromes c (Cytochrome c)IBA 06/2008 - 12/2004
2	Caspase 9IBA 06/2008 - 12/2004
2	Monoclonal AntibodiesIBA 01/2005 - 03/2002
2	Caspase 8 (Caspase-8)IBA 01/2005 - 12/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2024
1	CholesterolIBA 01/2024
1	Nerve Growth Factors (Neurotrophins)IBA 12/2022
1	Complement Inactivating AgentsIBA 06/2021

Therapy/Procedure

20	Photochemotherapy (Photodynamic Therapy) 01/2021 - 07/2002
19	Therapeutics 06/2021 - 10/2002
16	Lasers (Laser) 11/2019 - 05/2002
6	Intravitreal Injections 04/2022 - 03/2002
4	Injections 01/2024 - 03/2002
4	Trabeculectomy (Trabeculoplasty) 09/2023 - 11/2021
3	Vitrectomy 01/2019 - 09/2002
2	Phacoemulsification 01/2023 - 01/2023
2	Operative Surgical Procedures 01/2022 - 09/2016
2	Light Coagulation 09/2021 - 06/2005
2	Intraocular Lenses (Intraocular Lens) 01/2019 - 09/2005
2	Intraperitoneal Injections 11/2016 - 01/2013
1	Filtering Surgery 03/2024
1	Blepharoplasty 02/2024
1	Transplantation 01/2023
1	Decompression 01/2023
1	Corneal Transplantation (Keratoplasty) 11/2022
1	Sutures (Suture) 01/2022
1	Suture Techniques 01/2022